This inventor holds 1 USPTO granted patent. Top assignee: Upstate Biotechnology, Inc.. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Thomas Jelinek: Innovator in Monoclonal Antibody Technology
Introduction
Thomas Jelinek is a notable inventor based in Lake Placid, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for various applications in molecular biology and medical research.
Latest Patents
Thomas Jelinek holds a patent for a recombinant monoclonal antibody to phosphotyrosine-containing proteins. This patent describes a purified or highly pure recombinant monoclonal antibody with 4G10-hybridoma type specificity. It includes polynucleotides, such as cDNA sequences, that encode the antibody chains and the corresponding amino acid sequences. The patent also discloses tagged sequences that are useful in molecular biological techniques.
Career Highlights
Jelinek is associated with Upstate Biotechnology, Inc., where he continues to advance his research and innovations. His work has been instrumental in enhancing the understanding and application of monoclonal antibodies in various scientific fields.
Collaborations
Some of his notable coworkers include Lynn Stiles and Arthur LaMarche. Their collaborative efforts contribute to the ongoing research and development in the biotechnology sector.
Conclusion
Thomas Jelinek's contributions to monoclonal antibody technology exemplify the impact of innovation in biotechnology. His patent and ongoing work at Upstate Biotechnology, Inc. highlight the importance of research in advancing medical and scientific knowledge.